𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of ZAP-70 in patients with chronic lymphocytic leukemia may change significantly during the course of the disease

✍ Scribed by L. Smolej; V. Vroblova; J. Novosad

Book ID
111415031
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
41 KB
Volume
30
Category
Article
ISSN
1751-5521

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The clinical course of lung carcinoma in
The clinical course of lung carcinoma in patients with chronic lymphocytic leukemia
✍ Kalpaj Parekh; Valerie Rusch; Mark Kris πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 2 views

## BACKGROUND. Although patients with chronic lymphocytic leukemia (CLL) have an increased risk of developing second primary malignancies, including lung carcinoma, there is virtually no information about their clinical outcomes. To evaluate this, the authors reviewed their 20-year institutional e

Comparison of methods for determining ze
Comparison of methods for determining zeta-chain associated protein – 70 (ZAP-70) expression in patients with B-cell chronic lymphocytic leukemia (B-CLL)
✍ Agnieszka Bojarska-Junak; Krzysztof Giannopoulos; Malgorzata Kowal; Anna DmoszyΕ„ πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 471 KB πŸ‘ 2 views

## Abstract ## Background: Zeta‐chain associated protein of 70kDa (ZAP‐70) is the most promising surrogate marker for the immunoglobulin heavy chain variable region (IgV~H~) mutation status in B‐cell chronic lymphocytic leukemia (B‐CLL). Crespo et al. proposed the detection of ZAP‐70 by flow cytom